Repligen (RGEN) Gains from Investment Securities (2013 - 2026)
Repligen's (RGEN) quarterly Gains from Investment Securities came in at $2.3 million in Q2 2026, up 129.07% year-over-year from $1.0 million in Q2 2025, and up 1680.82% quarter-over-quarter from -$146000.0 in Q1 2026.
Powered by 
Analysis
Repligen (RGEN) Gains from Investment Securities (2013 - 2026) Analysis & Trends
Repligen (RGEN) has reported Gains from Investment Securities for 9 consecutive years, with $2.3 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Gains from Investment Securities rose 129.07% year-over-year to $2.3 million in Q2 2026; TTM through Jun 2026 was -$3.5 million, a 26.16% increase from a year earlier, with the FY2025 full-year figure at -$13.6 million, down 526.42% from the prior year.
- Gains from Investment Securities was $2.3 million for Q2 2026 at Repligen, up from -$146000.0 in the prior quarter.
- Over five years, Gains from Investment Securities peaked at $3.2 million in Q4 2024 and troughed at -$34.3 million in Q3 2023.
- A 5-year average of -$4.8 million and a median of -$1.9 million in 2022 frame the typical range for Gains from Investment Securities.
- Across the five-year window, Gains from Investment Securities slumped 1385.15% in 2023 and surged 357.82% in 2024, its largest moves.
- Over 5 years, Gains from Investment Securities stood at -$17.1 million in 2022, then soared by 104.07% to $697000.0 in 2023, then surged by 357.82% to $3.2 million in 2024, then slumped by 147.63% to -$1.5 million in 2025, then soared by 251.84% to $2.3 million in 2026.
- The last three Gains from Investment Securities figures came in at $2.3 million (Q2 2026), -$146000.0 (Q1 2026), and -$1.5 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn |
| 10 | Bruker | 9.26 Bn | 9.04 Bn | 416.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.31 Mn |
| Mar 31, 2026 | -146,000.00 |
| Dec 31, 2025 | -1.52 Mn |
| Sep 30, 2025 | -4.15 Mn |
| Jun 30, 2025 | -7.94 Mn |
| Dec 31, 2024 | 3.19 Mn |
| Dec 31, 2023 | 697,000.00 |
| Sep 30, 2023 | -34.29 Mn |
| Jun 30, 2023 | 1.79 Mn |
| Mar 31, 2023 | 1.24 Mn |
| Dec 31, 2022 | -17.13 Mn |
| Sep 30, 2022 | -2.31 Mn |
| Jun 30, 2022 | -6.88 Mn |
| Mar 31, 2022 | -2.41 Mn |
| Dec 31, 2016 | -75,000.00 |
| Sep 30, 2016 | 675,000.00 |
| Jun 30, 2016 | 637,000.00 |
| Mar 31, 2016 | 2.01 Mn |
| Dec 31, 2015 | 1.97 Mn |
| Sep 30, 2015 | 233,000.00 |